Last update 08 Aug 2026

Allogeneic Anti-BCMA/GPRC5D Bispecific CAR-NK Cell(Acellytron Therapeutics)

Overview

Basic Info

Drug Type
CAR-NK
Synonyms
ACT-001(Acellytron Therapeutics)
Target
BCMA x GPRC5D
Action
modulators
Mechanism
BCMA modulators(B-cell maturation protein modulators), GPRC5D modulators(G-protein coupled receptor family C group 5member D modulators)
Therapeutic Areas
NeoplasmsImmune System DiseasesHemic and Lymphatic Diseases
Active Indication
Multiple Myeloma
Inactive Indication-
Originator Organization
Wuxi Aislichuang Biotechnology Co., Ltd.
Active Organization
Wuxi Aislichuang Biotechnology Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhaseClinical
First Approval Date-
Regulation-

Related

2
Clinical Trials associated with Allogeneic Anti-BCMA/GPRC5D Bispecific CAR-NK Cell(Acellytron Therapeutics)
NCT06594211
/ Not yet recruitingNot ApplicableIIT
A Single-Arm, Open-Label Study of Allogeneic Anti-BCMA/GPRC5D Bispecific CAR-NK Cells (ACT-001) in Patients With Relapsed or Refractory Multiple Myeloma
ChiCTR2300074598
/ Not yet recruitingPhase 2IIT
A single arm, multicenter evaluation of the safety and efficacy of ACT001 combined with radiotherapy in the newly diagnosed diffuse intrinsic pontine gliomas Phase II Clinical Study
100 Clinical Results associated with Allogeneic Anti-BCMA/GPRC5D Bispecific CAR-NK Cell(Acellytron Therapeutics)
Login to view more data
100 Translational Medicine associated with Allogeneic Anti-BCMA/GPRC5D Bispecific CAR-NK Cell(Acellytron Therapeutics)
Login to view more data
100 Patents (Medical) associated with Allogeneic Anti-BCMA/GPRC5D Bispecific CAR-NK Cell(Acellytron Therapeutics)
Login to view more data
100 Deals associated with Allogeneic Anti-BCMA/GPRC5D Bispecific CAR-NK Cell(Acellytron Therapeutics)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Multiple MyelomaClinical
China
Wuxi Aislichuang Biotechnology Co., Ltd.
09 Oct 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free